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Abstract: Behavioral alterations in dogs are not easy to understand and cure. The situation is more
difficult when an encephalitis due to Canine Distemper Virus (CDV) and a concomitant olfactory
neuroblastoma are present. This case report deals with the story of a 5-year-old Swiss shepherd dog
with behavioral changes, seizures, epistaxis and ataxia. Following clinical and laboratory exams,
a suspected diagnosis of CDV infection was hypothesized, and a therapy based on Ω-interferon
was administered. Every supporting therapy failed and the worsening of the clinical conditions led
to the euthanasia of the patient. A neoformation in the right frontal lobe was found post mortem.
Histopathology and immunohistochemistry investigation showed a non-suppurative demyelinating
encephalitis, suggestive of CDV infection, and a desmoplastic epithelioid olfactory neuroblastoma.
To the best of authors’ knowledge, this is the first clinical pathological report of a non-suppurative
encephalitis due to CDV infection and olfactory neuroblastoma in a dog.
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1. Introduction
Dogs are nowadays considered family members, and consequently, when pets start to display
undesirable behavior, the relationship could be damaged. It is hard to understand the reasons
for destructiveness, fear, anxiety, and even aggressiveness, and the evaluation can be difficult,
both for owners and veterinarians; some tools, like questionnaires for owners, educational training
and clinical examination, can be performed to understand the causes of the behavioral alteration and
to try to find a solution. However, there are some cases that are not only related to psychological
troubles, but that demonstrate systemic or neurologic pathologies.
2. Case History
Our report deals with the case of a 5-year-old male Swiss shepherd dog that lived in Turin
(Italy). The dog began to demonstrate behavioral abnormalities, like a tendency to stay alone,
lack of sociability with other dogs, and aggressiveness towards owners. The first line intervention was
educational training with a canine educator, who tried to manage the patient and, in the absence of
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results, recommended a visit to a veterinarian behaviorist; treatment with fluoxetine (1 mg/kg orally
once a day) and then, in the absence of results, with clomipramine hydrochloride (2 mg/kg orally once
a day), was administered. The behavioral status remained unchanged even with drug administration
for another 6 months, but suddenly the patient was referred for emergency treatment to clinicians
(Dario Candini and Cristina Vercelli) for a seizure, which was controlled with a single administration of
diazepam (0.2 mg/kg intravenously (IV)) and phenobarbital (3 mg/kg IV). When the emergency was
solved, the clinicians spoke with owners to collect anamnestic information, and when the condition of
the patient was stable, a complete physical examination was performed. The dog demonstrated
ataxic gait, tremors leading to ataxia, right nostril epistaxis and ipsilateral eye lachrymation,
congested mucosae, body temperature at 38.9 ◦C, and no alteration at thoracic auscultation and
abdomen examination. Anamnesis recorded regular vaccination until the age of 3.5 years for
Canine Distemper Virus (CDV-Onderstepoort strain), Canine Adenovirus (Manhattan LPV3 strain),
Canine Parvovirus (Intervet 154 strain), Parainfluenza virus, and Leptospirosis (Leptospira interrogans
serovars canicola and icterohaemorrhagiae). Prophylaxis against filariosis, leishmaniosis and ectoparasites
was administered regularly.
The following differential diagnoses were hypothesized: idiopathic epilepsy, infective or parasitic
disease causing encephalitis (i.e., toxoplasmosis, Neospora caninum, distemper virus, erlichiosis,
rickettsiosis) central nervous system neoplasia or metabolic syndrome (i.e., hypoglicemia, secondary hepatic
encephalophaty due to a shunt, hypo/hyperadrenocortisism) [1]. Blood analysis showed no significant
alterations, other than a decrease of creatinekinase (CK) and total protein levels. Serum protein
electrophoresis revealed a decrease of α1 and β1 globulins, and an increase of α2 and β2 fractions.
Immunenzymatic rapid test to detect antigens of CDV (Quick test-Whitness) resulted positive, while rapid
tests for toxoplasmosis, filariosis, and leishmaniosis resulted negative. X-ray of the head showed intense
radiopacity involving the right nostril, without bone alteration. Owners did not accept performance
of a magnetic resonance imaging (MRI) scan, but permitted the collection of cerebrospinal fluid (CSF).
Cytology revealed moderate mononuclear pleocytosis (75% little lymphocytes, 20% neutrophils and 5%
macrophages), indicating a nonsuppurative encephalitis. One-step real time PCR (Qiagen company,
Hilden, Germany) on nucleic acid extracted from CSF, amplifying a 335bp fragment using a first primer of
5′ GATAAAGCATGTCATTATAGTCCTAA 3′ and second primer of 5′ CTTGAGCTTTCGACCCTTC 3′
(Trizol, Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA), demonstrated CDV in CSF.
A nasal wash was performed, and cytological analysis showed neutrophils including coccobacilli,
along with squamous metaplasia and strong dysplasia of the epithelial cells, concordant to a mucopurulent
rhinitis, coherent with CDV nasal epithelium colonization [2].
The suspected diagnosis was CDV.
Administration of phenobarbital (2.5 mg/kg orally twice a day) was always maintained,
and feline recombinant Ω-interferon (VirbagenOmega, Virbac—2.5 UM/kg IV for 3 consecutive
days) was started. The antiviral effectiveness of Ω-interferon against CDV was established to be
four times higher than α-interferon against CDV [3]. The therapy was repeated after 4 weeks.
During the following three months, serial clinical examinations and determination of barbituremia
were performed; no improvements of the clinical conditions were seen, and every supporting therapy
failed. During the last two weeks, the dog was anorexic, ataxic, and became blind.
Veterinarians and owners agreed to proceed with the euthanasia, and the dog was submitted to
post mortem examination.
External body examination did not show significant alterations, except for the slimming.
The brain was collected and gross examination of nasal cavity shown a stringy exudate in the right
frontal sinus, along with a wide, irregular, brown-white and firm lesion, measuring 3.5 × 3 × 3 cm,
occupying the right frontal lobe and compressing the contiguous cerebral parenchyma (Figure 1A).
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Figure 1. (A) Macroscopic aspect of tumor that was found in the right frontal sinus of a 5-year-old 
male Swiss shepherd dog, along with a wide, irregular, brown-white and firm lesion, measuring 3.5 × 
3 × 3 cm, occupying the right frontal lobe and compressing the contiguous cerebral parenchyma; (B) 
Round-to-oval cells organized in sheets or pseudorosettes supported by hypocellular zones of 
delicate fibrillary stroma; 40×; (C) Neoplastic cells densely organized. The picture shows the 
positivity for citokeratines, 20×; (D) The picture shows tumor cells isolated or small cluster, that were 
immunopositive for NF; 20×. 
Brain, thoracic and abdominal organs were fixed in a 10% buffered formalin solution and 
routinely embedded in paraffin wax blocks. Subsequently, 4 µm tissue sections were cut for 
histopathologic and immunohistochemical (IHC) evalutations. 
Microscopically, no significant histological abnormalities were detected in the thoracic and 
abdominal organs. The brain lesion was unencapsulated, infiltrative and composed by markedly 
pleomorphic, round-to-oval cells (with round- to oval-shaped nuclei, dispersed chromatin and 
prominent nucleoli), sometimes densely organized in nests or pseudorosettes supported by 
hypocellular zones of fibrillary stroma (Figure 1B). A total of 3–4 mitosis per high-power field (HPF, 
40×) were counted. Multifocal and large areas of necrosis, hemorrhages and perivascular 
lymphocytic cuffing were also observed. Selected samples of the neoformation were specifically 
immunolabeled (Table 1).  
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Brain, thoracic and abdominal organs were fixed in a 10% buffered formalin solution and routinely
embedded in paraffin wax blocks. Subsequently, 4 µm tissue sections were cut for histopathologic and
immunohistochemical (IHC) evalutations.
Microscopically, no significant histological abnormalities were detected in the thoracic and
abdominal organs. The brain lesion was unencapsulated, infiltrative and composed by markedly
pleomorphic, round-to-oval cells (with round- to oval-shaped nuclei, dispersed chromatin and
prominent nucleoli), sometimes densely organized in nests or pseudorosettes supported by
hypocellular zones of fibrillary stroma (Figure 1B). A total of 3–4 mitosis per high-power field (HPF,
40×) were counted. Multifocal and large areas of necrosis, hemorrhages and perivascular lymphocytic
cuffing were also observed. Selected samples of the neoformation were specifically immunolabeled
(Table 1).
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Table 1. Antibodies and their dilution used to perform immunohistochemistry on the brain mass.
Antibody Type/Company Dilution Tumour Stroma
Vimentin Monoclonal Mouse, Anti-Vimentin, Clone V9,Dako, Glostrup, Denmark 1:200 − +
Cytokeratins Monoclonal Mouse, Anti-Human Cytokeratins,Clones AE1/AE3, Dako, Glostrup, Denmark 1:50 + −
Glial fibrillary acidic
protein (GFAP)
Polyclonal Rabbit, Anti-Glial Fibrillary Acidic
Protein, Dako, Glostrup, Denmark 1:5000 − +
S-100 Polyclonal Rabbit, Anti-Cow S-100, Z0311, Dako,Glostrup, Denmark 1:200 − +
Neuron enolase (NSE)
Monoclonal Mouse, Anti-Human Neuron Specific
Enolase, Clone BBS/NC/VI-H14, Dako, Glostrup,
Denmark
1:500 + −
Neurofilament (NF) Monoclonal Mouse, Anti-Human NeurofilamentProtein, Clone 2F11, Dako, Glostrup, Denmark 1:10,000 + −
Densely organized neoplastic cells were negative for Glial fibrillary acidic protein (GFAP),
vimentin and S-100, while isolated or small cluster tumor cells were intensely immunopositive for
Neuron enolase (NSE), Neurofilament (NF), and cytokeratins (Figure 1C,D). Stroma demonstrated
moderate to severe immunopositivity for vimentin, GFAP and S-100. The Ki-67 proliferation index
ranged from 47.75% to 75.5%. Histopathological and immunohistochemical findings led to the
diagnosis of olfactory neuroblastoma (ONB). Multifocal and moderate vacuolization of the white
matter indicating demyelination, associated with the presence of some vacuolizations, glial cells,
small vessel proliferation and a mild non suppurative inflammation, was observed in the cerebral
cortex, mesencephalon and pons. Multifocal and mild leptomeningitis with perivascular cuffing,
mostly composed by lymphocytes, plasma cells and macrophages were observed in all brain sections.
Cerebrum, pons and mesencephalon sections were immunolabeled using a D110, a specific monoclonal
antibody for CDV (positive control: cerebellum of a puppy dead for CDV), according to the method
described by Bollo et al. [4], but resulted negative.
Based on the gross, microscopical and immunohistochemical results, and according to Beineke et al. [5],
the neurological signs of the dog of this report were caused by a concomitant distemper encephalitis and
an olfactory neuroblastoma.
3. Discussion
In the present case report, the identification of neurological symptoms at clinical examination was
partially suggestive of CDV infection. Indeed, the diagnosis was confirmed only by cytological analysis
and real-time PCR (RT-PCR) of the CSF. At post mortem examination, moderate and disseminated
demyelination associated with the presence of axonal degeneration, glial proliferation and nonsuppurative
inflammation were observed as the most relevant brain lesions. The identification of demyelinating
encephalomyelitis in white matter is the main manifestation of CDV, and is in agreement with previous
reports [5–7]. The present case report demonstrated a moderate and disseminated demyelination associated
with the presence of axonal degeneration and glial proliferation. These demyelinated areas could be
responsible for seizures and also for behavioral alterations [8]. On the other hand, intracranial neoplasia
could also cause the same symptoms, and might also be responsible for epistaxis, sneezing and nasal
discharge, which might be suggestive of tumors [9].
The lack of positivity of IHC for D110 could be explained by the administration of feline recombinant
Ω-interferon, which is characterized by high antiviral activity [3]. The hypothesis of an atypical
CDV infection, as reported by Galán et al. [10], was taken into account. However, the presence of
an inflammatory reaction may indicate that a slow viral infection rather than a totally masked or
latent virus could be involved. Another form of non-purulent encephalitis, old dog encephalitis (ODE),
which is an extremely rare manifestation of CDV-encephalitis and is characterized by progressive cortical
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deterioration due to chronic multifocal lymphoplasmacytic encephalitis with extensive perivascular cuffing
and astrocytosis, was also considered [11]. ODE usually occurs in dogs older than 6 years, most frequently
with a complete vaccination history [12]. Considering the rapid evolution of the neurological symptoms
and the identification of different histopathological findings in the dog of the present case report, an ODE
diagnosis was excluded.
The post mortem examination allowed the identification of a concomitant olfactory neuroblastoma
(ONB), which is a rare and malignant neuroectodermal tumor that derives from olfactory neuroepithelium,
arises within the upper nasal cavity at the level of the cribriform plate [13], and may extend to the paranasal
cavity and intracranial cavities [14]. The common clinical presentation of nasal tumors that extend into
the intracranial cavity includes exhibiting seizures and abnormal behavior, rather than signs suggestive of
upper respiratory disease [14]. The knowledge about the correlation between behavioral changes and the
presence of intracranial tumors is very poor in veterinary medicine. Some physicians have investigated
the correlation between human personality changes and psychiatric disturbances following brain tumors,
which could be mainly due to the putative role of organic mechanisms such as location of the lesion,
or effects of surgical treatment [15].
The histopathological features of tumor cells observed in the dog of the present case report are
consistent with those reported in previous studies about ONBs [13]. Furthermore, the presence of high
mitotic activity (demonstrated by the number of mitosis per HPF and the Ki-67 proliferation index),
marked cell pleomorphism and extended necrosis suggested the diagnosis of a less differentiated
histotype and indicated the malignancy of the tumor.
It was demonstrated that a correlation between the presence of virus and tumors in animals exists;
some examples include pulmonary adenocarcinoma in sheep caused by a retrovirus, and species-specific
oncogenes in rodents, fowl, feline and fish [16]. Moreover, early-age exposure (fetal or neonatal age)
can cause permanent alterations of the immune system that could possibly induce tumor formation [16].
Nevertheless, a direct correlation between the CDV and the onset of ONB has not been previously assessed.
On the contrary, it has been reported that some viruses (e.g., rabies) could be used to trace neuronal
cells [17], and also that several attenuated Newcastle Disease Virus (NDV) strains were evaluated in
pre-clinical studies in murine xenograft models where an efficacy against several human cancers such as
colon, large cell lung, breast, prostate carcinomas, and neuroblastoma demonstrated a regression upon
NDV treatment [18].
Taking into account all this information, in the authors’ opinion, it is not possible either to exclude
a prodromic effect of the CDV regarding ONB, or the limitation of the expansion of the tumor due to
the simultaneous presence of the distemper virus.
4. Conclusions
In the present paper, the authors reported the case of a 5 years old Swiss shepherd dog that,
at the beginning, showed behavioral changes and epilepsy, followed by an intra vitam diagnosis
of CDV. The post mortem investigation demonstrated a concomitant olfactory neuroblastoma and
a demyelinating encephalitis.
To the best of the authors’ knowledge, this is the first clinicopathological description of the
simultaneous presence of ONB and CDV brain infection in a dog.
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